Educational guide
Publication Stroll: Learn more about Influenza & Peptides
Publication Stroll: Learn more about Influenza & Peptides Published on 11/01/2024 In the midst of this cold winter, seasonal infection rates are not slowing down, and monitoring the Influenza virus while developing effective vaccines is imperative to minimize
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Publication Stroll: Learn more about Influenza & Peptides
Published on 11/01/2024
In the midst of this cold winter, seasonal infection rates are not slowing down, and monitoring the Influenza virus while developing effective vaccines is imperative to minimize the impact of the disease. As the leading peptide manufacturer for Influenza A & B antigens, we strive to meet this demand providing PepMix Peptide Pools and PepStar Peptide Microarrays for cellular and humoral immune monitoring, respectively.
Check our list of catalog Influenza products , send us a quote request for custom peptides or discuss your research projects with our experienced team .
With our extensive Influenza catalog, we have been able to contribute to wide range of research, a selection of which is presented here:
Concomitant Administration of Seasonal Influenza and COVID-19 mRNA Vaccines Aydillo et al., Emerging Microbes & Infections (2023) – PMID: 38054302 Products used: PepMix Influenza A (HA/H1N1/Victoria/2019), PepMix Influenza A (HA/H3N2/Darwin/2021) , Custom PepMix for Influenza B Nucleoprotein
Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza Tjärnhage et al., Journal of Virology (2023) – PMID: 36719241 Products used: PepMix Influenza A (HA/Puerto Rico/8/1934 H1N1), PepMix Influenza A (HA /California (H1N1))
Immunological Imprinting of Humoral Immunity to SARS-CoV-2 in Children Dowell et al., Nature Communications (2023) – PMID: 37386081 Products used: PepMix SARS-CoV-2 (Spike B.1.1.529 / BA.1 / Omicron), PepMix Influenza A (MP1/California/ (H3N2))
Characterization of Host and Bacterial Contributions to Lung Barrier Dysfunction Following Co-infection with 2009 Pandemic Influenza and Methicillin Resistant Staphylococcus aureus Nickol et al., Viruses (2019) – PMID: 30699912 Products used: custom PepStar Peptide Microarrays
Caracterización del agotamiento de los linfocitos T en pacientes con síndrome Long COVID Benéitez, Thesis (2023) Products used: PepMix Influenza A (HA/California (H1N1)), custom PepMix for Influenza A (HA/Perth (H3N2))